#Tcellimmunity
353 participants randomized to receive either bivalent mRNA vaccine (Moderna, n=177) or protein vaccine (Novavax, n=176), with a control group (n=143)
Follow-up at 6 - 12 months measuring antibody responses & #Tcellimmunity
March 20, 2026 at 12:04 PM
Webinar: Save-the-Date 🚨 June 10, 12-1pm CST
🦠 BK Virus-Specific T-Cell Immunity After Kidney Transplantation – Interim Analysis

Join Ambreen Azhar, MD, MS, Assistant Professor, Internal Medicine, Virginia Commonwealth University

Register below:👇

🧵

#BKvirus #BK #TcellImmunity
May 22, 2026 at 8:18 PM
This study has some limitations, such as the inability to investigate IgG anti-S antibody levels after the 1st, 2nd, and 3rd doses of the vaccine; therefore, it was not possible to compare the antibody levels after each vaccination. #Tcellimmunity has not yet been evaluated.
December 6, 2025 at 6:01 AM
Age and viral evolution reduce CD4⁺ T cell reactivity to the conserved iCope epitope, while humoral cross reactivity remains mutation sensitive only. 
#ImmuneEscape #TCellImmunity #PanCoronavirus

👤EVBC: Andreas Nitsche
📄
Aging and Viral Evolution Impair Immunity Against Dominant Pan‐Coronavirus‐Reactive T Cell Epitope
The immunodominant pan-coronavirus epitope iCope spans amino acids 816–830 within the fusion domain of the SARS-CoV-2 spike glycoprotein. This region exhibits a comparatively low mutation rate, espec...
doi.org
August 12, 2025 at 7:47 AM
Deployment of existing methods for measuring #Tcellimmunity could provide a more complete profile of immune status, informing #publichealth policies and interventions…

www.science.org/doi/10.1126/...
Understanding T cell responses to COVID-19 is essential for informing public health strategies
Deployment of broad-based strategies to measure vaccine-induced T cell immunity can significantly inform public health policies and interventions.
www.science.org
May 6, 2024 at 8:58 AM
Targeting ROCK2 may offer a therapeutic approach for chronic graft-versus-host disease (#cGVHD). This phase Ib study finds encouraging responses and a manageable safety profile with TDI01, a highly selective ROCK2 inhibitor.

#STTT #OpenAccess: doi.org/10.1038/s413...
#Fibrosis #TCellImmunity
September 21, 2026 at 10:00 AM
This study shows that CD28–PI3K signaling suppresses PANK4 via #PDK1 to control de novo lipid synthesis, and Pank4 deletion boosts CoA synthesis, #glutaminolysis, and CD4⁺ T-cell proliferation. #TCellImmunity #medsky

#STTT #OpenAccess: doi.org/10.1038/s413...
September 23, 2025 at 8:30 AM
Humoral and T-Cell Responses Following MVA-BN Booster Vaccination Against Mpox Virus Clades Ib and IIb
Antinori, A., Bettini, A. et al.
Paper
Details
#MpoxVaccine #HumoralResponse #TCellImmunity
July 8, 2025 at 9:01 AM